|
SON expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.221800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.185200E-01 |
| Normal-vs-Stage2 |
4.554600E-01 |
| Normal-vs-Stage3 |
2.802700E-03 |
| Normal-vs-Stage4 |
5.754900E-04 |
| Stage1-vs-Stage2 |
8.867800E-01 |
| Stage1-vs-Stage3 |
1.097970E-02 |
| Stage1-vs-Stage4 |
3.801400E-03 |
| Stage2-vs-Stage3 |
1.254560E-01 |
| Stage2-vs-Stage4 |
6.242200E-02 |
| Stage3-vs-Stage4 |
5.836000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.660360E-02 |
| Normal-vs-AfricanAmerican |
3.208800E-01 |
| Normal-vs-Asian |
8.824400E-01 |
| Caucasian-vs-AfricanAmerican |
5.551200E-01 |
| Caucasian-vs-Asian |
5.680800E-01 |
| AfricanAmerican-vs-Asian |
7.572200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.958300E-03 |
| Normal-vs-Female |
5.216000E-01 |
| Male-vs-Female |
6.721000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.189950E-02 |
| Normal-vs-Age(41-60Yrs) |
2.219000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.382200E-03 |
| Normal-vs-Age(81-100Yrs) |
2.140000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.125780E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.254800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.508000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.532500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.653800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.360600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.002200E-02 |
| Normal-vs-Grade 2 |
7.573400E-01 |
| Normal-vs-Grade 3 |
2.798000E-03 |
| Normal-vs-Grade 4 |
4.28310000000209E-06 |
| Grade 1-vs-Grade 2 |
1.023640E-01 |
| Grade 1-vs-Grade 3 |
3.618000E-03 |
| Grade 1-vs-Grade 4 |
8.22150000000521E-05 |
| Grade 2-vs-Grade 3 |
1.375750E-03 |
| Grade 2-vs-Grade 4 |
1.50643999999867E-05 |
| Grade 3-vs-Grade 4 |
2.373700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.322000E-01 |
| Normal-vs-ccB subtype |
3.93859999999746E-05 |
| ccA subtype-vs-ccB subtype |
3.81120000003676E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.746300E-02 |
| Normal-vs-N1 |
2.242300E-02 |
| N0-vs-N1 |
2.910000E-01 |
|
|
